Takara Bio Europe AB (Cellartis)

Jättestudie: Fördelarna med fetmaläkemedel – och riskerna

Läkemedel som Ozempic kan minska risken för en rad olika sjukdomar och hälsotillstånd, men också öka risken för andra komplikationer. Det enligt en stor amerika...

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

Forskningscenter stoppas på grund av brister – ”Väldigt allvarligt”

Forskning som bedrivs utan tillstånd. Bristande kvalitetssäkring. Personuppgifter som hanteras felaktigt. Kritiken mot arbetet på Center for Bionics and Pain Re...

Nanoparticles to help detect pulmonary disease

Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinat...

Precision medicine centre: “Extensive activity on several fronts”

Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...

Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...

Astra Zeneca investerar miljarder i ny anläggning i USA

Svensk-brittiska Astra Zeneca satsar på cellterapier. Nu investerar läkemedelsbolaget 300 miljoner dollar, motsvarande cirka 3,1 miljarder svenska kronor, i en ...

Icoat Medical startar vetenskapligt råd

Stockholmsbolaget Icoat Medical startar ett vetenskapligt råd med syfte att stärka bolagets forskning och utvecklingsprogram. Rådet består av tre läkare med exp...

Ny teknik förenklar 3D-printing av läkemedel

Vilka är de senaste trenderna inom 3D-utskrifter av läkemedel? Thomas Kipping ska besvara den frågan på Life Science Swedens möte.

Svensk-danskt event blir e-möte

I september anordnas Life Science Swedens två event The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability för första...

New report: Fewer PhDs in life sciences

A new report from Vinnova suggests that competency returns in the life science sector are declining.

Study: Chat GPT is more empathetic than doctors

The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic t...

"Unclear proposal from the EU Commission on how to solve the MDR challenges"

Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...

New Updates in Drug Formulation & Bioavailability: AI hett område

AI är en av de revolutionerande tekniker som kommer att omforma läkemedelsindustrin, säger Anders Broo, AstraZeneca, Mölndal.

New drug alert in the US: Rise in overdoses linked to the use of drugs for animals

A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time

According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the ...

He saved lives with his theories – was ostracised and ended up in a mental hospital

Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with...

Hög biologisk ålder kopplas till ökad risk för demens och stroke

Människor åldras i olika takt, som bekant. Nu indikerar en studie vid Karolinska institutet att personer med högre biologisk ålder än deras faktiska ålder löper...

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Glad sommar! – och chefredaktörens lästips

Life Science Swedens chefredaktör sammanfattar året hittills och ger lästips inför sommaren.

Nya patent stärker Alzecures globala skydd

Forskningsbolaget Alzecure Pharma har beviljats nya patent i Kina, Indien och fyra andra länder för Alzheimerskandidaten ACD856.

The TFS family is growing

TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the ...